Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo
Susan Ashton
1
,
Young-Ho Song
2
,
Jim Nolan
2
,
Elaine Cadogan
1
,
Jim Murray
3
,
RAJESH ODEDRA
1
,
John Foster
4
,
Peter A. Hall
4
,
Susan Low
2
,
Paula Taylor
1
,
Rebecca Ellston
1
,
Urszula M. Polanska
1
,
Joanne Wilson
1
,
Colin Howes
1
,
Aaron Smith
1
,
Richard J. A. Goodwin
4
,
John G Swales
4
,
Nicole Strittmatter
5
,
Zoltán Takáts
5
,
Anna Nilsson
6
,
Per Andrén
6
,
Dawn Trueman
1
,
Mike Walker
1
,
Corinne L Reimer
7
,
Greg Troiano
2
,
Donald Parsons
2
,
David De Witt
2
,
Marianne Ashford
3
,
Jeff Hrkach
2
,
Stephen Zale
2
,
Philip J. Jewsbury
1
,
Simon T. BARRY
1
2
BIND Therapeutics, 325 Vassar Street, Cambridge, MA 02139, USA.
|
7
Oncology iMED, AstraZeneca, Gatehouse Park, Waltham, Boston 02451, USA.
|
Publication type: Journal Article
Publication date: 2016-02-10
scimago Q1
wos Q1
SJR: 6.722
CiteScore: 27.9
Impact factor: 14.6
ISSN: 19466234, 19466242
PubMed ID:
26865565
General Medicine
Abstract
A nanoparticle formulation of an Aurora B kinase inhibitor uses ion pairing to achieve controlled release and efficacious, nontoxic target inhibition in tumors.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
2
4
6
8
10
12
|
|
|
Journal of Controlled Release
12 publications, 6.35%
|
|
|
International Journal of Pharmaceutics
6 publications, 3.17%
|
|
|
Pharmaceutics
4 publications, 2.12%
|
|
|
Advanced Drug Delivery Reviews
4 publications, 2.12%
|
|
|
Molecular Pharmaceutics
4 publications, 2.12%
|
|
|
Molecular Cancer Therapeutics
4 publications, 2.12%
|
|
|
Nature Reviews Drug Discovery
3 publications, 1.59%
|
|
|
Drug Delivery and Translational Research
3 publications, 1.59%
|
|
|
AAPS Journal
3 publications, 1.59%
|
|
|
Nature Communications
3 publications, 1.59%
|
|
|
Scientific Reports
3 publications, 1.59%
|
|
|
Journal of Pharmaceutical Sciences
3 publications, 1.59%
|
|
|
ACS Nano
3 publications, 1.59%
|
|
|
Analytical Chemistry
3 publications, 1.59%
|
|
|
Advances in Cancer Research
3 publications, 1.59%
|
|
|
Current Medicinal Chemistry
2 publications, 1.06%
|
|
|
Nanomedicine
2 publications, 1.06%
|
|
|
Oncotarget
2 publications, 1.06%
|
|
|
Nanomaterials
2 publications, 1.06%
|
|
|
International Journal of Molecular Sciences
2 publications, 1.06%
|
|
|
Frontiers in Pharmacology
2 publications, 1.06%
|
|
|
Nature Reviews Materials
2 publications, 1.06%
|
|
|
Pharmaceutical Research
2 publications, 1.06%
|
|
|
Biomaterials
2 publications, 1.06%
|
|
|
Drug Discovery Today
2 publications, 1.06%
|
|
|
Biochemical and Biophysical Research Communications
2 publications, 1.06%
|
|
|
Molecular Therapy
2 publications, 1.06%
|
|
|
Advanced Therapeutics
2 publications, 1.06%
|
|
|
Bioconjugate Chemistry
2 publications, 1.06%
|
|
|
2
4
6
8
10
12
|
Publishers
|
10
20
30
40
50
60
70
|
|
|
Elsevier
63 publications, 33.33%
|
|
|
Springer Nature
31 publications, 16.4%
|
|
|
American Chemical Society (ACS)
15 publications, 7.94%
|
|
|
MDPI
12 publications, 6.35%
|
|
|
Wiley
12 publications, 6.35%
|
|
|
Taylor & Francis
8 publications, 4.23%
|
|
|
American Association for Cancer Research (AACR)
8 publications, 4.23%
|
|
|
Bentham Science Publishers Ltd.
7 publications, 3.7%
|
|
|
Royal Society of Chemistry (RSC)
5 publications, 2.65%
|
|
|
American Association for the Advancement of Science (AAAS)
4 publications, 2.12%
|
|
|
Frontiers Media S.A.
3 publications, 1.59%
|
|
|
AME Publishing Company
3 publications, 1.59%
|
|
|
Impact Journals
2 publications, 1.06%
|
|
|
SAGE
2 publications, 1.06%
|
|
|
European Respiratory Society (ERS)
1 publication, 0.53%
|
|
|
1 publication, 0.53%
|
|
|
IOP Publishing
1 publication, 0.53%
|
|
|
MedCrave Group Kft.
1 publication, 0.53%
|
|
|
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 0.53%
|
|
|
Index Copernicus
1 publication, 0.53%
|
|
|
Walter de Gruyter
1 publication, 0.53%
|
|
|
Proceedings of the National Academy of Sciences (PNAS)
1 publication, 0.53%
|
|
|
Institute of Electrical and Electronics Engineers (IEEE)
1 publication, 0.53%
|
|
|
Cold Spring Harbor Laboratory
1 publication, 0.53%
|
|
|
IMR Press
1 publication, 0.53%
|
|
|
Rockefeller University Press
1 publication, 0.53%
|
|
|
National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications)
1 publication, 0.53%
|
|
|
10
20
30
40
50
60
70
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
189
Total citations:
189
Citations from 2025:
16
(8.47%)
Cite this
GOST |
RIS |
BibTex
Cite this
GOST
Copy
Ashton S. et al. Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo // Science Translational Medicine. 2016. Vol. 8. No. 325.
GOST all authors (up to 50)
Copy
Ashton S., Song Y., Nolan J., Cadogan E., Murray J., ODEDRA R., Foster J., Hall P. A., Low S., Taylor P., Ellston R., Polanska U. M., Wilson J., Howes C., Smith A., Goodwin R. J. A., Swales J. G., Strittmatter N., Takáts Z., Nilsson A., Andrén P., Trueman D., Walker M., Reimer C. L., Troiano G., Parsons D., De Witt D., Ashford M., Hrkach J., Zale S., Jewsbury P. J., BARRY S. T. Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo // Science Translational Medicine. 2016. Vol. 8. No. 325.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1126/scitranslmed.aad2355
UR - https://doi.org/10.1126/scitranslmed.aad2355
TI - Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo
T2 - Science Translational Medicine
AU - Ashton, Susan
AU - Song, Young-Ho
AU - Nolan, Jim
AU - Cadogan, Elaine
AU - Murray, Jim
AU - ODEDRA, RAJESH
AU - Foster, John
AU - Hall, Peter A.
AU - Low, Susan
AU - Taylor, Paula
AU - Ellston, Rebecca
AU - Polanska, Urszula M.
AU - Wilson, Joanne
AU - Howes, Colin
AU - Smith, Aaron
AU - Goodwin, Richard J. A.
AU - Swales, John G
AU - Strittmatter, Nicole
AU - Takáts, Zoltán
AU - Nilsson, Anna
AU - Andrén, Per
AU - Trueman, Dawn
AU - Walker, Mike
AU - Reimer, Corinne L
AU - Troiano, Greg
AU - Parsons, Donald
AU - De Witt, David
AU - Ashford, Marianne
AU - Hrkach, Jeff
AU - Zale, Stephen
AU - Jewsbury, Philip J.
AU - BARRY, Simon T.
PY - 2016
DA - 2016/02/10
PB - American Association for the Advancement of Science (AAAS)
IS - 325
VL - 8
PMID - 26865565
SN - 1946-6234
SN - 1946-6242
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2016_Ashton,
author = {Susan Ashton and Young-Ho Song and Jim Nolan and Elaine Cadogan and Jim Murray and RAJESH ODEDRA and John Foster and Peter A. Hall and Susan Low and Paula Taylor and Rebecca Ellston and Urszula M. Polanska and Joanne Wilson and Colin Howes and Aaron Smith and Richard J. A. Goodwin and John G Swales and Nicole Strittmatter and Zoltán Takáts and Anna Nilsson and Per Andrén and Dawn Trueman and Mike Walker and Corinne L Reimer and Greg Troiano and Donald Parsons and David De Witt and Marianne Ashford and Jeff Hrkach and Stephen Zale and Philip J. Jewsbury and Simon T. BARRY},
title = {Aurora kinase inhibitor nanoparticles target tumors with favorable therapeutic index in vivo},
journal = {Science Translational Medicine},
year = {2016},
volume = {8},
publisher = {American Association for the Advancement of Science (AAAS)},
month = {feb},
url = {https://doi.org/10.1126/scitranslmed.aad2355},
number = {325},
doi = {10.1126/scitranslmed.aad2355}
}